The flexible, iterative and potentially powerful nature of workshops makes them well suited to solving many kinds of problems, but sadly many workshops are poorly prepared or moderated and the results don't always justify the investment (in time as much as money). Atstrat brings vast experience and proven methodology to deliver excellent workshop experiences and outcomes.
Every Atstrat Collaborative Creativity Session (CCS), uses creative exercises specifically devised for the stated objective and the group of participants. Because of the bespoke nature of our workshops, the bulk of our effort is invested in preparing - ensuring that the time we have with the participants is put to maximum use and is as enjoyable as possible for them. We ensure the focus and confluence of ideas is on the key issues and always construct our workshops to minimise group-think traps and follow-the-leader pitfalls. And the output of a CCS (or a series of CCS) is not just descriptive of what happened, it contains expert analysis and interpretation, providing a clear point of view and where appropriate, recommended action.
Whether you aim to innovate, define a strategy, align internal thinking or gain new perspectives on the customer experience, our multi-activity CCS are always custom designed to deliver outstanding results. The following are descriptions of the most common types of CCS.
Defining the right strategy is crucial. Atstrat helps brands conceive and execute their best strategy through Collaborative Creativity. Where appropriate we start the process by mining for high-quality customer insights (HCP CCS and Patient/Caregiver CCS), then we involve key internal stakeholders in bespoke creative exercises - inspiring them to express their knowledge and opinions in devising market winning ideas that respect and enhance your brand.
Many factors - related to the complexity of the stakeholder galaxy - strongly influence healthcare brand performance and comprehending the gritty reality of key stakeholders is crucial. Atstrat involves HCPs in Collaborative Creativity Sessions (sometimes in multidisciplinary teams) to uncover their needs, desires, convictions, restrictions and biases - guiding them in imagining scenarios that potentially improve their current professional experience.
Any idea is only as effective at its execution allows it to be. Internal stakeholders who aren't aligned, don't completely comprehend, disagree with or are uninspired by a strategy that is handed down to them can distort it or disable its full realisation. Involving internal stakeholders in a Collaborative Creativity Session - immersing them in the process and allowing them to express their knowledge and perspectives - permits them to achieve full comprehension and co-ownership of the strategy, together with a clear output of coordinated actions to execute.
Patients and caregivers are the end beneficiaries of healthcare, but only recently has their voice become particularly influential and informed. Changes in attitude, technology and even regulation are accelerating the rise of the importance of patient opinion and knowledge. Atstrat is particularly invested in involving patients and caregivers in Collaborative Creativity Sessions to help brands understand the emotional and practical aspects of their journey and the expectations they harbour.
Alessandra has worked in advertising and marketing since 1996.
A sociologist, with a specialisation in semiotic analysis of consumer behaviour, she started work in DDB as a copywriter subsequently became Strategic Planner and progressed to Strategic Planning Director. While in DDB she moved to the Chicago headquarters working on J&J and Novartis OTC and DTC projects.
Returning to Italy she joined McCann Erickson Healthcare as director of the OTC BU, managing clients that included: Bracco; La Praire; Guaber; GSK; Pfizer; Recordati.
In 2006 she became General Manager of inVentiv Health Communication Italy (now Syneos Health) and later CEO. There she successfully created a strong and motivated team who serviced clients that included: Angelini; Bayer; Biogen; Bionike; Boiron; Chiesi; Daiichi Sankyo; Eli Lilly; Gilead; GSK; Intermune; Ipsen; Iroko; Janssen Cilag; J&J; Mylan; Novartis; Nutricia Danone; Ratiopharm; Ratiopharm Direct; Reckitt Benckiser; Recordati; Sapio Life; Shire; Sicor (Teva group); Sigma Tau; Zambon.
In 2016 she left inVentiv Health and created Atstrat.
A pioneer of the earliest Patient Support Programmes and Patient Adherence Programmes in Italy, today she specialises in Patient Experience Design - always working in collaboration with relevant stakeholders: PAGs, Patients/Caregivers, Institutions and HCPs.
In 2020, following her experience as a caregiver in her family, she began www.pazientiprotagonisti.it (Patient Protagonists), a podcast series where she interviews people who work in patient advocacy and occasionally patients who are supported by a patient advocacy group. This is a personal project she cares deeply about because she believes in the importance of supporting NGOs and she is convinced that their work should receive greater recognition.
She also volunteers for the Italian scleroderma advocacy association, ‘Gruppo Italiano Lotta alla Sclerodermia.’
Peter has worked in advertising and marketing since 1983.
For the first 20 years, he worked in global and local advertising agencies in creative roles for clients including; Bacardi, Cinzano, FIAT Auto, Invicta, Kinder Ferrero, L'Oréal, SanPaolo IMI, The Bridge e Warsteiner.
In 1999, while continuing his role as Creative Director, he founded and directed as Managing Director a web agency (sold in 2004) developing digital projects for clients including; American Airlines, Caffarel, Cressi-sub, Ferrero, Gabetti, Huhtamaki, UNICRI and Versace.
In 2004, he founded, in Milan, a healthcare agency in partnership with inVentiv Health (now Syneos Health) - a leading global healthcare services corporation. Subsequently he became Chief Creative Officer inVentiv Health Europe, increasing his strategic role providing international workshops and global communications strategies for clients that included; CSL-Behring, Daiichi-Sankyo, GSK, Eli Lilly, Ipsen, Merck, Shire, Sigma Tau.
In 2014 he moved into a consulting role and in 2016 founded Atstrat.
In 2020 he wrote 'The Forces of Collaborative Creativity' which was published worldwide in October.
You can learn more about Peter from his website.